These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9200923)

  • 1. [Peptide binding motif for HLA class I and autoimmune disease].
    Sakaguchi T; Takiguchi M
    Nihon Rinsho; 1997 Jun; 55(6):1397-402. PubMed ID: 9200923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structure of MHC molecules and binding peptides].
    Takiguchi M
    Nihon Rinsho; 1994 Nov; 52(11):2817-23. PubMed ID: 7996674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
    Nishimura Y
    Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
    Harris PE; Colovai A; Liu Z; Dalla Favera R; Suciu-Foca N
    J Immunol; 1993 Dec; 151(11):5966-74. PubMed ID: 8245441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I MHC-peptide interaction: structural and functional aspects.
    Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
    Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis.
    D'Amato M; Fiorillo MT; Carcassi C; Mathieu A; Zuccarelli A; Bitti PP; Tosi R; Sorrentino R
    Eur J Immunol; 1995 Nov; 25(11):3199-201. PubMed ID: 7489765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
    Wildner G; Thurau SR
    Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
    Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
    Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 and disease: a consequence of inadvertent antigen presentation?
    Benjamin R; Parham P
    Rheum Dis Clin North Am; 1992 Feb; 18(1):11-21. PubMed ID: 1561398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
    Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
    J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.
    Gambacorti-Passerini C; Bertazzoli C; Dermime S; Scardino A; Schendel D; Parmiani G
    Clin Cancer Res; 1997 May; 3(5):675-83. PubMed ID: 9815736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HLA-binding-motif-aided peptide epitope library: a novel library design for the screening of HLA-DR4-restricted antigenic peptides recognized by CD4+T cells.
    Tana T; Kamikawaji N; Savoie CJ; Sudo T; Kinoshita Y; Sasazuki T
    J Hum Genet; 1998; 43(1):14-21. PubMed ID: 9609993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide binding to empty HLA-B27 molecules of viable human cells.
    Benjamin RJ; Madrigal JA; Parham P
    Nature; 1991 May; 351(6321):74-7. PubMed ID: 2027387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended repertoire of permissible peptide ligands for HLA-B*2702.
    Raghavan M; Lebrón JA; Johnson JL; Bjorkman PJ
    Protein Sci; 1996 Oct; 5(10):2080-8. PubMed ID: 8897608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.